These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39549549)

  • 1. Inhibition of hepatic PCSK9 as a novel therapeutic target ameliorates metabolic steatohepatitis in mice.
    Mijiti T; Chen X; Ma X; Ma Y; Ma X; Chen B
    Int Immunopharmacol; 2024 Dec; 143(Pt 3):113621. PubMed ID: 39549549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP13 ameliorates metabolic dysfunction-associated steatohepatitis through targeting PTEN.
    Tang M; Wei X; Ma Y; Tan Y; Cao H; Yao S; Wang J; Yang H; Liu F; Peng Y; Fan N
    Life Sci; 2025 Jan; 360():123264. PubMed ID: 39571890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition and prevention method in viral infection.
    Muzammil K; Hooshiar MH; Varmazyar S; Omar TM; Karim MM; Aadi S; Kalavi S; Yasamineh S
    Microb Cell Fact; 2024 Mar; 23(1):90. PubMed ID: 38528584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dodecanedioic acid prevents and reverses metabolic-associated liver disease and obesity and ameliorates liver fibrosis in a rodent model of diet-induced obesity.
    Angelini G; Russo S; Carli F; Infelise P; Panunzi S; Bertuzzi A; Caristo ME; Lembo E; Calce R; Bornstein SR; Gastaldelli A; Mingrone G
    FASEB J; 2024 Nov; 38(22):e70202. PubMed ID: 39600104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase 3 activity enhances liver inflammation in MASH.
    Khoury M; Guo Q; Furuta K; Correia C; Meroueh C; Kim Lee HS; Warasnhe K; Valenzuela-Pérez L; Mazar AP; Kim I; Noh YK; Holmes H; Romero MF; Sussman CR; Pavelko KD; Islam S; Bamidele AO; Hirsova P; Li H; Ibrahim SH
    JHEP Rep; 2024 Jun; 6(6):101073. PubMed ID: 38882600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
    Fang S; Yarmolinsky J; Gill D; Bull CJ; Perks CM; ; Davey Smith G; Gaunt TR; Richardson TG
    PLoS Med; 2023 Jan; 20(1):e1003988. PubMed ID: 36595504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual dimorphism in the effects of maternal adipose tissue growth hormone receptor deficiency on offspring metabolic health.
    Ran L; Wang X; Ma R; Wang H; Wu Y; Yu Z
    Biol Sex Differ; 2024 Dec; 15(1):98. PubMed ID: 39623508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tauroursodeoxycholate on arsenic-induced hepatic injury in mice: A comparative transcriptomic analysis.
    Zheng X; Cao J; Wang H; Liu L; Jin B; Zhang H; Li M; Nian S; Li H; He R; Wang N; Li X; Wang K
    J Trace Elem Med Biol; 2024 Dec; 86():127512. PubMed ID: 39232337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative transcriptomics and lipidomics unravels the amelioration effects of Radix Bupleuri on non-alcoholic fatty liver disease.
    Wang W; Qin J; Bai S; Tian J; Zhou Y; Qin X; Gao X
    J Ethnopharmacol; 2025 Feb; 338(Pt 1):119005. PubMed ID: 39490432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of intestinal Ticam1 ameliorated MASH via Akkermansia muciniphila QAA37749.1 mediated betaine transformation.
    Li Z; Gao W; Yuan H; Pan X; Yuan R; Wang W; Guan L; Hu L; Chen Y; Cheng Z; He R; Zhang L; Yang B; Zhu Q; Liang M; Seki E; Lin R; Chu H; Yang L
    Biochim Biophys Acta Mol Basis Dis; 2025 Jan; 1871(1):167571. PubMed ID: 39536991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for preventing weight gain after smoking cessation.
    Hartmann-Boyce J; Theodoulou A; Farley A; Hajek P; Lycett D; Jones LL; Kudlek L; Heath L; Hajizadeh A; Schenkels M; Aveyard P
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD006219. PubMed ID: 34611902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of abstinence-based and harm reduction-based interventions in reducing problematic substance use in adults who are experiencing homelessness in high income countries: A systematic review and meta-analysis: A systematic review.
    O'Leary C; Ralphs R; Stevenson J; Smith A; Harrison J; Kiss Z; Armitage H
    Campbell Syst Rev; 2024 Jun; 20(2):e1396. PubMed ID: 38645303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagenase injection versus limited fasciectomy surgery to treat Dupuytren's contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation.
    Dias J; Tharmanathan P; Arundel C; Welch C; Wu Q; Leighton P; Armaou M; Corbacho B; Johnson N; James S; Cooke J; Bainbridge C; Craigen M; Warwick D; Brady S; Flett L; Jones J; Knowlson C; Watson M; Keding A; Hewitt C; Torgerson D
    Health Technol Assess; 2024 Dec; 28(78):1-262. PubMed ID: 39644138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-to-head comparison among FAST, MAST, and multiparametric MRI-based new score in diagnosing at-risk MASH.
    Imajo K; Saigusa Y; Kobayashi T; Nagai K; Nishida S; Kawamura N; Doi H; Iwaki M; Nogami A; Honda Y; Kessoku T; Ogawa Y; Kirikoshi H; Kokubu S; Utsunomiya D; Takahashi H; Aishima S; Sumida Y; Saito S; Yoneda M; Dennis A; Kin S; Andersson A; Nakajima A
    Eur Radiol; 2024 Dec; ():. PubMed ID: 39638942
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.